Cutler Group LP Novavax Inc Call Options Transaction History

Cutler Group LP

15 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2023 Jul 18, 2023	SELL	$6.67 - $9.52 $28,014 - $39,984	-4,200 Reduced 59.15%	2,900 $0
Q1 2023 May 01, 2023	SELL	$5.76 - $12.48 $168,192 - $364,416	-29,200 Reduced 80.44%	7,100 $1,000
Q4 2022 Feb 07, 2023	BUY	$8.86 - $25.04 $193,148 - $545,872	21,800 Added 150.34%	36,300 $11,000
Q3 2022 Oct 25, 2022	SELL	$18.2 - $76.12 $374,920 - $1.57 Million	-20,600 Reduced 58.69%	14,500 $2,000
Q2 2022 Aug 04, 2022	SELL	$36.28 - $75.29 $1.99 Million - $4.13 Million	-54,800 Reduced 60.96%	35,100 $58,000
Q1 2022 Apr 14, 2022	BUY	$69.73 - $142.9 $1.09 Million - $2.23 Million	15,600 Added 21.0%	89,900 $298,000
Q4 2021 Jan 18, 2022	BUY	$134.56 - $217.97 $7.58 Million - $12.3 Million	56,300 Added 312.78%	74,300 $437,000
Q3 2021 Oct 26, 2021	SELL	$177.8 - $270.58 $71,120 - $108,232	-400 Reduced 2.17%	18,000 $720,000
Q2 2021 Jul 19, 2021	BUY	$121.0 - $257.67 $157,300 - $334,971	1,300 Added 7.6%	18,400 $749,000
Q1 2021 Apr 26, 2021	BUY	$112.98 - $319.93 $723,072 - $2.05 Million	6,400 Added 59.81%	17,100 $759,000
Q4 2020 Jan 21, 2021	SELL	$78.74 - $139.5 $622,046 - $1.1 Million	-7,900 Reduced 42.47%	10,700 $333,000
Q3 2020 Oct 27, 2020	SELL	$79.44 - $178.51 $1.44 Million - $3.23 Million	-18,100 Reduced 49.32%	18,600 $483,000
Q2 2020 Jul 22, 2020	BUY	$13.86 - $83.61 $234,234 - $1.41 Million	16,900 Added 85.35%	36,700 $447,000
Q1 2020 May 07, 2020	SELL	$3.93 - $16.0 $786 - $3,200	-200 Reduced 1.0%	19,800 $31,000
Q2 2019 Aug 09, 2019	BUY	$4.93 - $12.2 $98,600 - $244,000	20,000 New	20,000 $0

291

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $674M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.